KP Tissue Inc. (TSE:KPT - Free Report) - Analysts at Desjardins increased their Q2 2025 earnings per share (EPS) estimates for KP Tissue in a research note issued on Wednesday, May 14th. Desjardins analyst F. Tremblay now forecasts that the company will earn $0.16 per share for the quarter, up from their prior estimate of $0.07. Desjardins currently has a "Hold" rating and a $9.50 target price on the stock. The consensus estimate for KP Tissue's current full-year earnings is $0.44 per share. Desjardins also issued estimates for KP Tissue's FY2025 earnings at $0.64 EPS.
Several other brokerages have also issued reports on KPT. TD Securities upped their target price on KP Tissue from C$8.00 to C$9.00 and gave the company a "hold" rating in a research report on Thursday. National Bankshares upped their target price on KP Tissue from C$8.50 to C$9.50 and gave the company a "sector perform" rating in a research report on Thursday.
Check Out Our Latest Research Report on KP Tissue
KP Tissue Stock Performance
TSE:KPT traded up C$0.01 during mid-day trading on Monday, hitting C$8.93. 22,242 shares of the company's stock traded hands, compared to its average volume of 15,897. The company has a fifty day moving average of C$8.15 and a 200 day moving average of C$8.12. KP Tissue has a twelve month low of C$7.54 and a twelve month high of C$8.95. The company has a market capitalization of C$89.25 million, a P/E ratio of 13.98, a P/E/G ratio of -0.88 and a beta of 0.37.
About KP Tissue
(
Get Free Report)
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Recommended Stories
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
